Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales: Moayyedi, Paul, Benchimol, Eric I, Armstrong, David, Yuan, Cathy, Fernandes, Aida, Leontiadis, Grigorios I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165259/
https://www.ncbi.nlm.nih.gov/pubmed/32328550
http://dx.doi.org/10.1093/jcag/gwaa004
_version_ 1783523438191706112
author Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
author_facet Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
author_sort Moayyedi, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-7165259
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71652592020-04-23 Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease Moayyedi, Paul Benchimol, Eric I Armstrong, David Yuan, Cathy Fernandes, Aida Leontiadis, Grigorios I J Can Assoc Gastroenterol Letters to the Editor Oxford University Press 2020-04 2020-04-18 /pmc/articles/PMC7165259/ /pubmed/32328550 http://dx.doi.org/10.1093/jcag/gwaa004 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title_full Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title_fullStr Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title_full_unstemmed Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title_short Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
title_sort response to comments on the cag/ccc position statement on biosimilars for inflammatory bowel disease
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165259/
https://www.ncbi.nlm.nih.gov/pubmed/32328550
http://dx.doi.org/10.1093/jcag/gwaa004
work_keys_str_mv AT moayyedipaul responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease
AT benchimolerici responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease
AT armstrongdavid responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease
AT yuancathy responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease
AT fernandesaida responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease
AT leontiadisgrigoriosi responsetocommentsonthecagcccpositionstatementonbiosimilarsforinflammatoryboweldisease

Ejemplares similares